Nuveen Asset Management’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $2.77M | Sell |
227,033
-6,533
| -3% | -$79.6K | ﹤0.01% | 2248 |
|
|
2024
Q3 | $3.91M | Buy |
233,566
+15,800
| +7% | +$264K | ﹤0.01% | 2102 |
|
|
2024
Q2 | $3.8M | Buy |
217,766
+124,544
| +134% | +$2.17M | ﹤0.01% | 2083 |
|
|
2024
Q1 | $1.59M | Buy |
93,222
+4,899
| +6% | +$83.5K | ﹤0.01% | 2500 |
|
|
2023
Q4 | $900K | Buy |
88,323
+9,707
| +12% | +$98.9K | ﹤0.01% | 2782 |
|
|
2023
Q3 | $711K | Buy |
78,616
+1,305
| +2% | +$11.8K | ﹤0.01% | 2717 |
|
|
2023
Q2 | $832K | Buy |
77,311
+5,103
| +7% | +$54.9K | ﹤0.01% | 2723 |
|
|
2023
Q1 | $739K | Sell |
72,208
-20,548
| -22% | -$210K | ﹤0.01% | 2708 |
|
|
2022
Q4 | $978K | Sell |
92,756
-14,604
| -14% | -$154K | ﹤0.01% | 2687 |
|
|
2022
Q3 | $1.38M | Buy |
107,360
+1,347
| +1% | +$17.3K | ﹤0.01% | 2588 |
|
|
2022
Q2 | $1.36M | Sell |
106,013
-1,455
| -1% | -$18.7K | ﹤0.01% | 2642 |
|
|
2022
Q1 | $1.38M | Sell |
107,468
-8,496
| -7% | -$109K | ﹤0.01% | 2682 |
|
|
2021
Q4 | $1.79M | Sell |
115,964
-77,228
| -40% | -$1.19M | ﹤0.01% | 2620 |
|
|
2021
Q3 | $4.36M | Buy |
193,192
+69,822
| +57% | +$1.58M | ﹤0.01% | 2285 |
|
|
2021
Q2 | $3.18M | Buy |
123,370
+73,634
| +148% | +$1.9M | ﹤0.01% | 2486 |
|
|
2021
Q1 | $2.07M | Buy |
+49,736
| New | +$2.07M | ﹤0.01% | 2599 |
|